FDA recall D-0725-2026

Fresenius Kabi USA, LLC · Class II · drug

Product

Glycopyrrolate Injection, USP, 1 mg per 5 mL (0.2 mg per mL), 25 x 5 mL fill in a 6.5 mL vial, Rx only, Multiple Dose Vials, Fresenius Kabi, Lake Zurich, IL 60047 NDC Tray: 63323-578-05; NDC Vial: 63323-578-07

Reason for recall

Presence of Particulate Matter: Hair was found in product

Distribution

Nationwide within in the USA

Key facts

Status
Ongoing
Initiation date
2026-07-16
Report date
2026-07-29
Voluntary/Mandated
Voluntary: Firm initiated
Location
Lake Zurich, IL, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0725-2026